| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |